Rockville Pike, MD -- (SBWIRE) -- 07/29/2019 -- Dual chamber prefilled syringes are being widely utilized for storing biological substances or active pharmaceutical components that cannot be stable for extended duration. These syringes enable avoiding drug loss by maintaining sterility of drugs prior to injection. Advancement in technology has resulted into improved arrangement of liquid components in syringes and injectors, attracting more patients toward opting for these safe and efficient syringes.
Lyophilized drugs have witnessed a robust penetration across the globe in the recent past. These drugs account for a major share of the all reconstitution-requiring injectable/infusible. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers. However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers. With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.
A CAGR of 8.7% has been projected for the global dual chamber prefilled syringes market during the forecast period, 2017 to 2026, according to a new study of Fact.MR. Roughly US$ 3,300 Mn worth of dual chamber prefilled syringes are likely to be sold across the globe by 2026-end.
For more incisive insights, Request a Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=486
Glass will remain preferred product material for dual chamber prefilled syringes, mainly because of its non-reactive nature, and properties such as chemical and heat resistance. However sales of glass prefilled syringes will witness a comparatively slower expansion than plastic prefilled syringes through 2026.
Although hospital pharmacies are estimated to account for the largest market share during the forecast period, sales of dual chamber prefilled syringes in online pharmacies are poised to record the highest CAGR through 2026.
Competition Tracking
With trend toward surging adoption of self-injection syringes, and development of technologically advanced dual chamber prefilled syringes, leading players in the market are concentrating on expansion of their product portfolio and the market reach. In this highly competitive and rapidly evolving market, players are emphasizing on the essentiality of up-to-date information for monitoring their performance and making critical decisions regarding profitability & growth.
Report Customization can be done @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=486
Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR's report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.
About Us
Fact.MR's methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.
Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.
The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.